Open for inclusion

A phase II study of pembrolizumab in patients with malignant peripheral nerve sheath tumor (MPNST), not eligible for curative surgery

Cancer type: MPNST

Phase: II

Principal Investigator: Guren Tormod

Country: NO

Keywords: Norway, Oslo, MPNST, pembrolizumab, Keytruda

Status: Open for inclusion

Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02691026?term=MPNST&rank=1